Ads
    Related paper
  1. Safety of Sofosbuvir and Daclatasvir in Patients having Ischemic Heart Disease for Treatment of HCV Compensated Cirrhosis |Biomedgrid
  2. Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
  3. Influence of koraksan treatment on vascular wall condition, immunology inflamation and heart rate variability and in patients with ischemic heart disease: stable angina pectoris II-III FC
  4. Remodeling of heart in patients with stable ischemic heart disease combined with chronic obstructive pulmonary disease as a basis for development of heart failure
  5. PROSPECTS OF RIVAROXABAN USE IN THE TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
  6. ADHERENCE TO TREATMENT IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCORDING TO THE REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA)
  7. Treatment Features of Ciliary Arrhythmia in Patients with Ischemic Heart Disease in Combination with Diabetes Innocens
  8. The Influence of Pathogenetic Treatment on Peroxidation in Patients with Ischemic Heart Disease and Comorbid Nonalcoholic Steatohepatitis
  9. Analysis of anxiety level in patients with myocardial revascularization compared with conservative approaches to the treatment of ischemic heart disease
  10. CHANGES OF THE HEART RATE VARIABILITY IN THE PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE DURING SESSION OF HYPERBARIC OXYGENATION THERAPY